Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, Novembe... ( SAN DIEGO Nov. 4 2009 /- Arena Pharma...)

Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, November 10, 2009

Date:11/4/2009

SAN DIEGO, Nov. 4, 2009 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced it will report third quarter 2009 financial results after the NASDAQ Global Market closes on Monday, November 9, 2009. The next morning, November 10, 2009, Jack Lief, Arena's President and Chief Executive Officer, and Robert E. Hoffman, Arena's Vice President, Finance and Chief Financial Officer, will host a conference call at 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time) to discuss the financial results for the third quarter 2009 and to provide a business and financial update.

The conference call may be accessed by dialing 888.452.4024 for domestic callers and 719.325.2385 for international callers. Please specify to the operator that you would like to join the "Arena Pharmaceuticals' Third Quarter 2009 Financial Results Call." The conference call will be webcast live under the investor relations section of Arena's website at www.arenapharm.com, and will be archived there for 30 days following the call. Please connect to Arena's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About Arena Pharmaceuticals

Arena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Arena's most advanced drug candidate, lorcaserin, is being investigated in a Phase 3 clinical trial program for weight management. Arena's broad pipeline of novel compounds target G protein-coupled receptors, an important class of validated drug targets, and includes compounds being evaluated independently and with partners, including Merck &
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:12/14/2009)... THE WOODLANDS, Texas, Dec. 14 /PRNewswire/ ... investigators affiliated with US Oncology ... were presented orally at the ... , held Dec. 9-13 at the ... in San Antonio, Texas . ...

(Date:12/14/2009)... Cardinal Health today announced that executives of ... ,, Goldman Sachs CEO Unplugged Conference ... Sachs Conference Center in New York. 28th ... at Noon EST at the Westin St. Francis Hotel ... executives will discuss Cardinal Health,s diverse products and services, ...

(Date:12/14/2009)... Southridge LLC ("Southridge"), an investment firm that provides ... announce that its affiliated fund has closed a private ... equity financing to Imaging Diagnostic Systems, Inc. (OTCBB: IMDS). ... growth of Imaging Diagnostic Systems, Southridge has paved a ... the field of early breast cancer detection," said Stephen ...

Breaking Medicine Technology:US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 2 US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 3 US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 4 US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 5 US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 6 US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 7 US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 8 US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 9 Cardinal Health Executives to Speak at Two Investor Events in January 2 Southridge LLC Provides Funding Through Private Equity Agreement with Imaging Diagnostic Systems, Inc. 2 Meda Introduces EDLUAR 28TM 29 the First and Only Sublingual Tablet That Contains the Most Prescribed Sleep Medication Zolpidem Tartrate 56404 1 Meda Introduces EDLUAR 28TM 29 the First and Only Sublingual Tablet That Contains the Most Prescribed Sleep Medication Zolpidem Tartrate 56404 2 Meda Introduces EDLUAR 28TM 29 the First and Only Sublingual Tablet That Contains the Most Prescribed Sleep Medication Zolpidem Tartrate 56404 3 Meda Introduces EDLUAR 28TM 29 the First and Only Sublingual Tablet That Contains the Most Prescribed Sleep Medication Zolpidem Tartrate 56404 4 Delta Health an InfoLogix Company Wins Engagement with Hennepin County Medical Center for Strategic Cost Management 56400 1 Delta Health an InfoLogix Company Wins Engagement with Hennepin County Medical Center for Strategic Cost Management 56400 2 Delta Health an InfoLogix Company Wins Engagement with Hennepin County Medical Center for Strategic Cost Management 56400 3 Genova files patent for new prostate cancer treatment 56395 1 Genova files patent for new prostate cancer treatment 56395 2

[0] US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium [0] Cardinal Health Executives to Speak at Two Investor Events in January [0] Southridge LLC Provides Funding Through Private Equity Agreement with Imaging Diagnostic Systems, Inc.

... at AASLD annual meeting, Pivotal Phase III ... failed prior treatment, SAN FRANCISCO, Nov. 1 ... that a planned interim analysis of a,Phase II ... C,protease inhibitor, in combination with peginterferon and ribavirin,markedly ...

... I Clinical Data and Additional Preclinical Results for Non-Nucleoside ... Polymerase Inhibitor Being Presented at AASLD, SAN DIEGO, Nov. ... the results of a Phase I clinical trial,of ANA598 in ... of the leading non-nucleoside polymerase inhibitors,currently in development for the ...

Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers

(Date:12/15/2009)... A study in the Dec. 15 issue ... indicates that significant associations exist between parent-reported ... and headaches in young school-aged children. , ... insomnia was 3.3 times more likely in children ... in children with headaches. Nineteen percent of ...

(Date:12/14/2009)... liposuction and fat transfer treatments can help people slim down, ... invasive treatment. , ... (PRWEB) December ... remove excess fat from the abdomen and inject it into ... facial wrinkling and enhance lips all in one safe, minimally ...

(Date:12/14/2009)... -- Haemonetics Corporation (NYSE: HAE ) ... legal action to stop Fenwal Inc.,s continued patent ... collection kits, using a modified separation chamber. ... Haemonetics, patent and the injunction entered by the ... after December 1, 2010. According to statements ...

(Date:12/14/2009)... gene, researchers say , , MONDAY, Dec. 14 (HealthDay News) ... in a single gene linked to heart failure. , ... St. Louis analyzed the DNA of a large group ... variants in four genes that could be connected with ... failure and 625 healthy whites led the researchers to ...

(Date:12/14/2009)... -- Skilled nursing facilities (SNFs) in Ohio are making ... deal with a 92 percent increase in the state-imposed ... $12.01 per bed per day, scheduled for December 15. ... pay an additional $17,520 to the state each month, ... $438,365 yearly. ,, Nearly 96 percent of skilled nursing ...

Breaking Medicine News(10 mins):Health News:Insomnia symptoms linked with medical complaints in young school-aged children 2 Health News:Insomnia symptoms linked with medical complaints in young school-aged children 3 Health News: Free Webinar Series at Aqualipo.com Shows How New Combination Liposuction/Fat Transfer Treatment Helps Patients Slim Down and Reduce Facial Wrinkling 2 Health News: Free Webinar Series at Aqualipo.com Shows How New Combination Liposuction/Fat Transfer Treatment Helps Patients Slim Down and Reduce Facial Wrinkling 3 Health News:Haemonetics Files a New Legal Action to Stop Fenwal Inc.'s Continued Patent Infringement 2 Health News:Haemonetics Files a New Legal Action to Stop Fenwal Inc.'s Continued Patent Infringement 3 Health News:Survey Shows Tax Increase Forcing Ohio Skilled Nursing Facilities to Make Cuts 2 Health News:Survey Shows Tax Increase Forcing Ohio Skilled Nursing Facilities to Make Cuts 3

[1] Insomnia symptoms linked with medical complaints in young school-aged children [0] Free Webinar Series at Aqualipo.com Shows How New Combination Liposuction/Fat Transfer Treatment Helps Patients Slim Down and Reduce Facial Wrinkling [0] Haemonetics Files a New Legal Action to Stop Fenwal Inc.'s Continued Patent Infringement [0] Contributors to Heart Failure Identified [1] Survey Shows Tax Increase Forcing Ohio Skilled Nursing Facilities to Make Cuts

... lead unhealthy lifestyles are more likely to suffer from ... population-based study of more than 5,000 men and women ... journal BJU International. Researchers hope the results will help ... can be managed more effectively. , According to ...

... Third Quarter Revenue Increased 70.9% to $9.2 Million, ... Co., Inc., (OTC Bulletin Board: TYNP), a manufacturer ... in,Chengdu, China, today announced fiscal results for its ... the third quarter of 2008 increased 70.9% to ...

... p.m. ET Thursday, May 22, WESTFORD, Mass., May ... developer and manufacturer of a broad array of,light-based aesthetic ... at the 2008 Citi Investment Research Global Health,Care Conference, ... presentation will be webcast live over the Internet,beginning at ...

... 15 Pain is a chief reason that,patients ... option,for these patients. Physicians must be able to ... for their patients., To make clinicians aware ... the dual journals Current Clinical Practice and The,Journal ...

... in mouse model hint of new treatment strategies for the ... polyunsaturated fat, the kind often found in baked and fried ... , The finding by University of California, Los Angeles, scientists ... a mouse model that closely mimics human cancer. , The ...

... Group (USA), Inc.,(the ,Company, or ,Tiens,), (Amex: TBV ), ... ended March 31, 2008., Revenue for the first quarter ... first quarter of 2007., Net income for the first ... to net income of $6.5 million, or $0.09 per share ...

Obesity and unhealthy lifestyles linked to more complex urinary problems Tianyin Pharmaceutical Co., Inc. Announces Third Quarter 2008 Financial Results Cynosure to Present at 2008 Citi Investment Research Global Health Care Conference Treat Your Patients' Pain Effectively Lowering Dietary Fat May Help Prevent Prostate Cancer Tiens Biotech Group (USA) Reports First Quarter Results

The dryer is designed to rapidly dry slides by blowing warm air over the surface of the slides. The slide dryer accommodates two slide racks directly from a stainer and allows the slides to be staine...

PRINCIPLE: The QC-SLIDES™ are specifically designed microscope slides intended to be part of the quality control program to monitor microbiological stains and staining techniques....

... have a positive and negative inoculated well, ... these slides, perform QC and sample staining ... education and training programs by testing QC ... on one slide! KWIK-QC slides contain the ...

... Well Plate Capability The Equalizer 384 ... Equalizerexpandable and equal tip spacing, choice of two ... In addition, this model allows you to evenly ... and accessing many gels and for use with ...

Medicine Products:

Forced Air Slide Dryer AFB STAIN CONTROL KWIK-QC™ Slides Impact2 Equalizer 384 8-Channel Electronic Pipettor, 0.5-12.5L

Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, Novembe...( SAN DIEGO Nov. 4 2009 /- Arena Pharma...),Health